Bulletin

WHO Executive Board appoints Regional Directors for Eastern Mediterranean, South-East Asia, and Western Pacific regions

January 23, 2024

Roche

European Commission approves Roche’s Tecentriq SC, the EU's first PD-(L)1 cancer immunotherapy subcutaneous injection for multiple cancer types

January 16, 2024

WHO

Preventing famine and deadly disease outbreak in Gaza requires faster, safer aid access and more supply routes

January 15, 2024

Press Information Bureau

Dr Mansukh Mandaviya inaugurates National Institute of Pharmaceutical Education and Research in Guwahati, Assam

January 12, 2024

WHO

WHO Certifies Cabo Verde as Malaria-Free, Marking a Historic Milestone in the Fight Against Malaria

January 12, 2024

WHO

Multi-country outbreak of cholera: situation report

January 11, 2024

Press Information Bureau

Union Health Minister Dr Mansukh Mandaviya inaugurates CDSCO Sub Zonal Office and Central Drug Testing Laboratory in Indore, Madhya Pradesh

January 7, 2024

Press Information Bureau

Union Minister of Health & Family Welfare Dr. Mansukh Mandaviya inaugurates the country’s 1st Healthy & Hygienic Food Street, 'PRASADAM,' at Neelkanth Van, Mahakal Lok, in Ujjain, Madhya Pradesh

January 7, 2024

WHO

WHO meets with Chinese officials on current COVID-19 situation

December 30, 2023

Press Information Bureau

CDSCO and State Drugs Control Administration commence joint inspection of Drug Manufacturing Units

December 27, 2023

Press Information Bureau

Union Minister of Health & Family Welfare, Dr. Mansukh Mandaviya interacts with doctors and representatives of IMA

December 26, 2023

Roche

FDA approves Roche’s Lunsumio, a first-in-class bispecific antibody, to treat people with relapsed or refractory follicular lymphoma

December 23, 2023

Press Information Bureau

National Health Authority organized ABDM adoption workshop for diagnostic industry representatives

December 22, 2023

Press Information Bureau

NHA aims to promote adoption of Ayushman Bharat Digital Mission (ABDM) by offering incentives of up to Rs. 4 crores to hospitals, labs and digital health solution providers

December 22, 2023

Roche

FDA approves Roche’s Actemra for the treatment of COVID-19 in hospitalised adults

December 22, 2023

WHO

WHO prequalifies a second Malaria vaccine, a significant milestone in prevention of the disease

December 21, 2023

< 1 … 31 32 33 34 35 36 37 38 39 … 94 >

Bulletin

WHO Executive Board appoints Regional Directors for Eastern Mediterranean, South-East Asia, and Western Pacific regions

European Commission approves Roche’s Tecentriq SC, the EU's first PD-(L)1 cancer immunotherapy subcutaneous injection for multiple cancer types

Preventing famine and deadly disease outbreak in Gaza requires faster, safer aid access and more supply routes

Dr Mansukh Mandaviya inaugurates National Institute of Pharmaceutical Education and Research in Guwahati, Assam

WHO Certifies Cabo Verde as Malaria-Free, Marking a Historic Milestone in the Fight Against Malaria

Multi-country outbreak of cholera: situation report

Union Health Minister Dr Mansukh Mandaviya inaugurates CDSCO Sub Zonal Office and Central Drug Testing Laboratory in Indore, Madhya Pradesh

Union Minister of Health & Family Welfare Dr. Mansukh Mandaviya inaugurates the country’s 1st Healthy & Hygienic Food Street, 'PRASADAM,' at Neelkanth Van, Mahakal Lok, in Ujjain, Madhya Pradesh

WHO meets with Chinese officials on current COVID-19 situation

CDSCO and State Drugs Control Administration commence joint inspection of Drug Manufacturing Units

Union Minister of Health & Family Welfare, Dr. Mansukh Mandaviya interacts with doctors and representatives of IMA

FDA approves Roche’s Lunsumio, a first-in-class bispecific antibody, to treat people with relapsed or refractory follicular lymphoma

National Health Authority organized ABDM adoption workshop for diagnostic industry representatives

NHA aims to promote adoption of Ayushman Bharat Digital Mission (ABDM) by offering incentives of up to Rs. 4 crores to hospitals, labs and digital health solution providers

FDA approves Roche’s Actemra for the treatment of COVID-19 in hospitalised adults

WHO prequalifies a second Malaria vaccine, a significant milestone in prevention of the disease

Company

Resources